Results 61 to 61 of about 90 (61)

P1‐392: DRUG DEVELOPMENT FOR AGITATION AND AGGRESSION IN ALZHEIMER'S DISEASE (AD): STUDY DESIGN AND OUTCOME MEASURES IN PHASE 2 STUDY OF SCYLLO‐INOSITOL (ELND005 STUDY AG201)

Alzheimer's & Dementia, 2014
Susan R. Abushakra, Patrick Kesslak, Matthias Kurth, Frank Fan, Menghis Bairu, David S. Miller, Constantine Lyketsos   +6 more
openaire   +1 more source